• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Journal of biopharmaceutical statistics

    Journal of biopharmaceutical statistics

    JournalISSN 1054-3406eISSN 1520-5711中科院 医学 4区

    年发文量

    研究主题

    论文(2543)

    排序
    1A Practical Evaluation of Finite-Sample BOIN Calibration and Bayesian Smoothing in Phase I Dose Finding
    Siyi Chen

    We evaluated an asymmetric loss-based BOIN boundary and a monotone Bernstein estimator. The boundary preserved lookup-table operation but did not improve correct selection uniformly in seven monotone scenarios. It reduced overdose selection relative to BOIN, aBOIN, and gBOINS in six. Its accuracy depended on MTD position and overdose aversion. Bernstein selection reduced accuracy in most scenarios, especially for middle and high MTDs. Reference MCMC showed that importance-sampling error did not explain these losses. Target-based elimination eventually removes a repeatedly sampled MTD when toxicity exceeds the target. An upper-equivalence-bound threshold avoids this asymptotic conflict but not finite-sample elimination. Standard BOIN should remain the default. The loss-based boundary is justified only when the protocol prespecifies overdose avoidance and calibration shows an acceptable tradeoff. The Bernstein estimator is not recommended in its present form.

    2026
    引用
    AI阅读
    加入学术空间
    2Beyond Covariate Balance: Statistical Resilience of Machine Learning-Augmented Inverse Probability Weighting Versus Entropy Balancing in Clinical Evidence Translation
    Aiden Yi-Fei Wang, Lu Mao, Xiu-Wen Ling, Atiqah Aziz,Han-Ling Tan, Terry Hao-Yu Qin
    2026
    引用
    AI阅读
    加入学术空间
    3Personalized Dynamic Dose-Finding for Longitudinal Observational Data: an Application to Glucose Intolerance in VLBW Infants
    Md Nasim Saba Nishat,Stella Self,Rahul Ghosal, Christine Schammel, Bryan L. Ohning, Mirinda Ann Gromley,Alexander C. McLain

    The prescribed doses for many drugs are based on population norms or vary between physicians. For example, very low birth weight (VLBW) infants (weighing less than 1500 grams at birth) experience slower postnatal growth than in utero and receive glucose infusions to mitigate nutritional disruption. Effective treatment dosing is critical to ensure adequate neonatal weight gain while minimizing the risk of hyperglycemia. A single uniform dose is impractical due to the substantial heterogeneity in glucose metabolism among infants. Furthermore, little is known about each infant’s glucose metabolism, which complicates the selection of the optimal dose value. We employ a flexible longitudinal mixed model to determine dynamic, patient-specific optimal doses for new infants. Empirical Bayes predictions of random effects are incorporated to capture individual dosage sensitivities that adapt as new data becomes available. To be viable in high-risk clinical environments, providing estimates of predictive uncertainty is crucial for supporting informed clinical decision-making that balances patient safety with treatment efficacy. We propose using the implicit value delta method to quantify the uncertainty of the predicted optimal doses. We validate the properties of our model through simulation studies and an analysis of VLBW infants in a neonatal intensive care unit (NICU) for the first 7 days of life, which demonstrates some key differences in optimal and prescribed dosing strategies.

    2026
    引用
    AI阅读
    加入学术空间
    4ANPP: the Adapted Normalized Power Prior for Borrowing Information from Multiple Historical Datasets in Clinical Trials
    Yueqi Shen,Matthew A. Psioda,Luiz M. Carvalho,Joseph G. Ibrahim

    The power prior is a popular class of informative priors for incorporating information from historical data. It involves raising the likelihood for the historical data to a power, which acts as a discounting parameter. When the discounting parameter is modeled as random, the normalized power prior (NPP) is recommended. When there are multiple historical datasets, there has been limited research on how to choose priors for the multiple discounting parameters of the NPP to induce desirable information borrowing behavior. In this work, we address this question by investigating the analytical relationship between the NPP and the Bayesian hierarchical model (BHM), which is a widely used method for synthesizing information from different sources. We develop the adapted normalized power prior (ANPP), which establishes dependence between the dataset-specific discounting parameters of the NPP, leading to inferences that are identical to the BHM. We establish a direct relationship between the prior for the dataset-specific discounting parameters of the ANPP and the prior for the variance parameter of the BHM. Establishing this relationship not only justifies the NPP from the perspective of hierarchical modeling but also achieves easy prior elicitation for the NPP for the purpose of dynamic borrowing. We examine the borrowing properties of the ANPP through simulations and apply it to a case study for a pediatric lupus trial.

    2026
    引用
    AI阅读
    加入学术空间
    5Accounting for Long-Term Survival: a Smoothed Piecewise Model for Event Time Projection in Cellular Immunotherapy Trials
    Zixing Wang, Qingyang Zhang, Jin Xie, Allen Xue,James Whitmore

    In clinical trials with time-to-event outcomes, one of the main tasks is predicting the number of events over time and the time to reach a specific number of events. This is particularly challenging in cellular immunotherapy trials due to the unique, time-dependent nature of the hazard rate. The typical survival pattern shows a high early event rate followed by a long-term survival plateau. While piecewise parametric survival models are commonly used to address this hazard heterogeneity, they often introduce abrupt changes in hazard rates between intervals. In this work, we extend it to a smoothed piecewise model for event-time prediction, aiming to reduce abrupt changes in hazard rates between adjacent intervals. Simulation studies and real trial examples demonstrate the enhanced utility and improved accuracy of our proposed methods for event-time prediction in cellular immunotherapy trials.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 2543 篇论文

    高被引作者

    作者引用发文
    Douglas G Altman23162
    Shein-Chung Chow134688
    Alex Dmitrienko92726
    Yi Tsong91076
    H. M. James Hung79518
    Craig H. Mallinckrodt6347
    Geert Molenberghs62636
    Yue Lilly55924
    Nigel Stallard5349
    Sue Jane Wang50717

    高产作者

    作者引用发文
    Shein-Chung Chow134688
    Yi Tsong91076
    Geert Molenberghs62636
    Jen-Pei Liu48331
    Meiyu Shen32628
    Alex Dmitrienko92726
    Yue Lilly55924
    Anastasia Ivanova19823
    Ram C. Tiwari39022
    Gary Koch24120

    相关期刊

    Statistical methods in medical research
    Lifetime Data Analysis
    Biostatistics
    Pharmaceutical Statistics
    The international journal of biostatistics
    Statistics in biopharmaceutical research
    Statistics in Biosciences
    Journal of clinical trials
    Journal of statistical research
    Biometrical Journal